C4 Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CCCC)

CUSIP: 12529R107

Q2 2025 13F Holders as of 30 Jun 2025

Security identity
Security type / class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
111,000,000
Holder snapshot
Total 13F shares
54,715,914
Share change
-9,583,907
Total reported value
$78,242,864
Reported price per share
$1.43
Number of holders
102
Value change
-$14,672,718
Number of buys
57
Number of sells
70

Security key

12529R107

Report period

Q2 2025

Institutions

102

Top holders

10

CCCC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 C4 Therapeutics, Inc. SEC filings C4 Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CCCC - C4 Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BlackRock, Inc.
13D/G signal
BlackRock, Inc.
Evidence rows
15
Latest as of
31 Mar 2025
13F 13D/G Lead comparable stake: 2.5% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
13F 13D/G
2.5%
from 13D/G
$8,455,060
5,284,413 shares
 — 31 Mar 2025
Lynx1 Capital Management LP
13F
Company
13F
6.4%
$11,357,013
7,098,133 shares
 — 31 Mar 2025
Soleus Capital Management, L.P.
13F
Company
13F
6.3%
$11,166,307
6,978,942 shares
 — 31 Mar 2025
ORBIMED ADVISORS LLC
13F
Company
13F
6.2%
$10,928,480
6,830,300 shares
 — 31 Mar 2025
WASATCH ADVISORS LP
13F
Company
13F
6.1%
$10,759,054
6,724,409 shares
 — 31 Mar 2025
MORGAN STANLEY
13F
Company
13F
3.6%
$6,472,526
4,045,329 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
102
Shares
54,715,914
Rows available
102
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
113
Q2 2025 holders
102
Holder diff
-11
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .